Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity
<b>Background/Objectives:</b> Recent studies, typically using patient cerebrospinal fluid (CSF), have suggested that different autoantibodies (Aabs) acting on their respective receptors, may underlie neuropsychiatric disorders. The GluN1 (NR1) subunit of the N-methyl-D-aspartate receptor...
Saved in:
| Main Authors: | Charlotte Day, John-Paul Silva, Rebecca Munro, Brice Mullier, Véronique Marie André, Christian Wolff, Gary J. Stephens, Angela Bithell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis the level of autoantibodies in diabetic ketoacidosis in pediatric practice
by: Yu. V. Bykov, et al.
Published: (2023-07-01) -
Endosomal sorting protein SNX4 limits synaptic vesicle docking and release
by: Josse Poppinga, et al.
Published: (2024-12-01) -
Future Perspectives of NMDAR in CNS Disorders
by: Toni Capó, et al.
Published: (2025-02-01) -
Hippocampal neuroinflammation and neuronal injury in the acute phase of pentylenetetrazol induced epilepsy mouse model
by: Linyu ZHI, et al.
Published: (2025-04-01) -
Spatiotemporal terahertz modulation enhances NMDAR-mediated miniature EPSCs
by: Shaolei Jiang, et al.
Published: (2025-07-01)